Trial reportAddiction (Abingdon, England)2019
Cost-effectiveness of electronic- and clinician-delivered screening, brief intervention and referral to treatment for women in reproductive health centers.
Trial report in Addiction (Abingdon, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- A Systematic Review of Evidence-Based Prevention Approaches for Alcohol Problems with Viability for Military Implementation.Military medicine · 2025Pooled it
- Cost-effective interventions to prevent prescription drug misuse: a systematic review.Frontiers in public health · 2025Pooled it
- Abstinence outcomes among women in reproductive health centers administered clinician or electronic brief interventions.Journal of substance abuse treatment · 2020Trial
- Effect of Motivational Interviewing on Exclusive Breastfeeding in Working Mothers: A Randomized Controlled Trial.Journal of primary care & community healthTrial
- Safe start, a hybrid intervention to reduce alcohol exposed pregnancies: protocol for a randomized controlled trial.BMC public health · 2026Article
- Site-randomised trial of a multilevel digital intervention to reduce maternal morbidity and mortality: a study protocol.BMJ open · 2025Article
- A study protocol for a site-randomized trial of a multi-level digital intervention to reduce maternal morbidity & mortality.medRxiv : the preprint server for health sciences · 2025Article
- Listening to Black Pregnant and Postpartum People: Using Technology to Enhance Equity in Screening and Treatment of Perinatal Mental Health and Substance Use Disorders.Journal of racial and ethnic health disparities · 2025Article
- Building and Beta-Testing Be Well Buddy Chatbot, a Secure, Credible and Trustworthy AI Chatbot That Will Not Misinform, Hallucinate or Stigmatize Substance Use Disorder: Development and Usability Study.JMIR human factors · 2025Article
- Feasibility trial of a technology-delivered intervention for opioid use disorder recovery postpartum.Journal of child & adolescent substance abuse · 2025Article
- Reducing Smoking Cessation Disparities: Capacity for a Primary Care- and Technology-Based Approach Among Medicaid Recipients.Journal of clinical psychology in medical settings · 2023Article
- Fetal alcohol spectrum disorders prevention and clinical guidelines research-workshop report.BMC proceedings · 2023Article
- Project BETTER: A Family-Centered, Technology-Delivered Intervention for Pregnant People with Opioid Use Disorder.Children (Basel, Switzerland) · 2023Article
- Online randomised factorial trial of electronic Screening and Brief Intervention for alcohol use in pregnancy: a study protocol.BMJ open · 2022Article
- Barriers and Considerations in the Design and Implementation of Digital Behavioral Interventions: Qualitative Analysis.Journal of medical Internet research · 2022Article
- Project BETTER: Preliminary Feasibility and Acceptability of a Technology-Delivered Educational Program for Pregnant and Postpartum People with Opioid Use Disorder.Women's health reports (New Rochelle, N.Y.) · 2022Article
- Evidence for the Effectiveness and Acceptability of e-SBI or e-SBIRT in the Management of Alcohol and Illicit Substance Use in Pregnant and Post-partum Women.Frontiers in psychiatry · 2021Review
- A Non-Randomized Trial of In-Person Versus Text/Telephone Screening, Brief Intervention and Referral to Treatment for Pregnant and Postpartum Women.Psychiatric research and clinical practice · 2021Article
- Alcohol Screening, Brief Intervention, and Referral to Treatment (SBIRT) for Girls and Women.Alcohol research : current reviews · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
aimsTo determine the cost-effectiveness of electronic- and clinician-delivered SBIRT (Screening, Brief Intervention and Referral to Treatment) for reducing primary substance use among women treated in reproductive health centers.
designCost-effectiveness analysis based on a randomized controlled trial.
settingNew Haven, CT, USA.
participantsA convenience sample of 439 women seeking routine care in reproductive health centers who used cigarettes, risky amounts of alcohol, illicit drugs or misused prescription medication.
interventionsParticipants were randomized to enhanced usual care (EUC, n = 151), electronic-delivered SBIRT (e-SBIRT, n = 143) or clinician-delivered SBIRT (SBIRT, n = 145). MEASUREMENTS: The primary outcome was days of primary substance abstinence during the 6-month follow-up period. To account for the possibility that patients might substitute a different drug for their primary substance during the 6-month follow-up period, we also considered the number of days of abstinence from all substances. Incremental cost-effectiveness ratios and cost-effectiveness acceptability curves determined the relative cost-effectiveness of the three conditions from both the clinic and patient perspectives.
findingsFrom a health-care provider perspective, e-SBIRT is likely (with probability greater than 0.5) to be cost-effective for any willingness-to-pay value for an additional day of primary-substance abstinence and an additional day of all-substance abstinence. From a patient perspective, EUC is most likely to be the cost-effective intervention when the willingness to pay for an additional day of abstinence (both primary-substance and all-substance) is less than $0.18 and e-SBIRT is most likely to be the cost-effective intervention when the willingness to pay for an additional day of abstinence (both primary-substance and all-substance) is greater than $0.18.
conclusionse-SBIRT could be a cost-effective approach, from both health-care provider and patient perspectives, for use in reproductive health centers to help women reduce substance misuse.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.